- News Home
27 November 2013 12:59 pm ,
Vol. 342 ,
The new head of the National Center for Science Education promises to "fight the good fight" against attacks on...
Analyses of the H7N9 strains isolated from four new cases show that the virus is evolving rapidly, heightening anxiety...
In 2009, Jack Szostak shared a Nobel Prize for his part in discovering the role of telomeres, the end bits of...
Science has exposed a thriving academic black market in China involving shady agencies, corrupt scientists, and...
Paper-selling agencies flourish in the aura of reputable businesses. For some scientists, it may be difficult to tell...
Featuring the first lunar rover in 40 years, Chang'e-3 is seen as an important milestone on China's quest to send a...
Data collected by satellites and floating probes have chronicled a 2-decade rise in the temperature and thickness of a...
Cholesterol, the artery-clogging molecule that contributes to cardiovascular disease, has another nasty trick up its...
- 27 November 2013 12:59 pm , Vol. 342 , #6162
- About Us
FDA's Expanded Mandate in Limbo
14 February 2011 5:45 pm
The U.S. Food and Drug Administration (FDA) could get a big budget boost this year, with the president requesting $4.3 billion, more than a third of it from regulatory fees paid by companies. That total is more than $1 billion higher than the 2010 budget figure. FDA has planned a number of new initiatives and is enjoying expanded authority in areas like food safety and tobacco control. But despite an outwardly rosy picture, the agency still doesn't have the cash in hand it needs to fulfill an expanded mandate.
2012 may or may not be the year when FDA gets to flex some new muscles. Among other things, the president is requesting $324 million for a new food safety initiative, to allow FDA to implement the recently passed Food Safety Modernization Act, designed to reduce food-borne disease. FDA also wants to put $49 million into strengthening regulatory science, for example by finding better ways to understand drug toxicity.
A continuing resolution just passed by appropriators in the House of Representatives provides only $3.3 billion for FDA's 2011 budget—far short of the Administration's 2012 objective—suggesting that it may be difficult to find common ground.
See our complete coverage of Budget 2012.